Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs, Directed Genomics Partner on NGS-based Target Enrichment Technology

NEW YORK (GenomeWeb) – New England Biolabs and Directed Genomics today announced a partnership to develop new next-generation sequencing-based target enrichment technologies.

The first product to be developed will be a target enrichment technology combining enrichment with NGS library construction into a single, seamless protocol. The partners said the approach is scalable and will enable researchers to convert small amounts of genomic DNA into sequence-ready libraries in about six hours. They added that enrichment is highly specific and enables greater coverage of target regions with fewer sequencing reads than currently available target-capture methods.

Financial and other terms of the deal were not disclosed.

"Partnering with NEB allows us to leverage an extensive knowledgebase of enzyme activities, best-in-class manufacturing practices, and their global commercial footprint," Directed Genomics Founder and President Cynthia Richard said in a statement.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.